Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Obstet Gynecol ; 132(3): 678-681, 2018 09.
Article in English | MEDLINE | ID: mdl-30095766

ABSTRACT

BACKGROUND: Intrahepatic cholestasis of pregnancy is an incompletely understood disease that poses significant fetal risks, including stillbirth. Treatment of intrahepatic cholestasis of pregnancy is aimed at relieving maternal symptoms and improving fetal outcomes. CASE: A 21-year-old gravid woman, 3 para 0111, presented at 27 2/7 weeks of gestation with severe intrahepatic cholestasis of pregnancy. Her clinical course was refractory to first-line therapy with ursodiol, and she was started on rifampin with rapid improvement of symptoms and transaminitis. Despite maternal improvement, she was delivered at 31 weeks of gestation for persistent nonreassuring fetal status. CONCLUSION: Rifampin may be an effective adjunctive therapy for intrahepatic cholestasis of pregnancy refractory to ursodiol alone. Additional research is needed to assess short-term and long-term maternal and newborn outcomes, because fetal deterioration still occurred in spite of maternal improvement.


Subject(s)
Cholestasis, Intrahepatic/drug therapy , Nucleic Acid Synthesis Inhibitors/therapeutic use , Pregnancy Complications/drug therapy , Rifampin/therapeutic use , Cholagogues and Choleretics/therapeutic use , Drug Therapy, Combination , Female , Humans , Pregnancy , Ursodeoxycholic Acid/therapeutic use , Young Adult
3.
J Pediatr Adolesc Gynecol ; 31(5): 485-489, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29753776

ABSTRACT

STUDY OBJECTIVE: To identify risk factors for primary nonelective cesarean delivery, in a predominantly Hispanic teen population of an urban tertiary care center. DESIGN: Retrospective descriptive study. SETTING: A tertiary academic center with approximately 3000 deliveries per year. PARTICIPANTS: Our study population comprised all women (ages 13-19 years at time of delivery) who gave birth at our tertiary university hospital between July 2011 and July 2016. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Our main outcome of interest was primary nonelective cesarean delivery. RESULTS: Of the 958 included deliveries, 9.6% (92/958) were delivered via nonelective cesarean section. The population was 89% Hispanic with a mean age of 17.7 years. Age, body mass index at delivery, and neonatal birth weight were significantly associated with delivery via cesarean section. Mothers of neonates with extremes of birth weights (<2500 g, >4000 g) had higher odds of having a cesarean delivery, compared with neonates with normal birth weight (odds ratio, 3.27; 95% confidence interval, 1.90-5.63 and odds ratio, 4.43; 95% confidence interval, 1.33-14.72). CONCLUSION: Among adolescent patients, age, body mass index at delivery, and birth weight of the neonate were found to be risk factors that place the gravid teen at increased risk for cesarean delivery.


Subject(s)
Cesarean Section/statistics & numerical data , Pregnancy in Adolescence/statistics & numerical data , Adolescent , Adult , Female , Hispanic or Latino/statistics & numerical data , Humans , Infant, Newborn , Pregnancy , Pregnancy in Adolescence/ethnology , Retrospective Studies , Risk Factors , Tertiary Care Centers , Young Adult
4.
J Clin Endocrinol Metab ; 102(12): 4557-4567, 2017 12 01.
Article in English | MEDLINE | ID: mdl-29053802

ABSTRACT

Context: Maternal obesity in pregnancy has profound impacts on maternal metabolism and promotes placental nutrient transport, which may contribute to fetal overgrowth in these pregnancies. The fatty acid docosahexaenoic acid (DHA) has bioactive properties that may improve outcomes in obese pregnant women by modulating placental function. Objective: To determine the effects of DHA supplementation in obese pregnant women on maternal metabolism and placental function. Design: Pregnant women were supplemented with DHA or placebo. Maternal fasting blood was collected at 26 and 36 weeks' gestation, and placentas were collected at term. Setting: Academic health care institution. Subjects: Thirty-eight pregnant women with pregravid body mass index ≥30 kg/m2. Intervention: DHA (800 mg, algal oil) or placebo (corn/soy oil) daily from 26 weeks to term. Main Outcomes: DHA content of maternal erythrocyte and placental membranes, maternal fasting blood glucose, cytokines, metabolic hormones, and circulating lipids were determined. Insulin, mTOR, and inflammatory signaling were assessed in placental homogenates, and nutrient transport capacity was determined in isolated syncytiotrophoblast plasma membranes. Results: DHA supplementation increased erythrocyte (P < 0.0001) and placental membrane DHA levels (P < 0.0001) but did not influence maternal inflammatory status, insulin sensitivity, or lipids. DHA supplementation decreased placental inflammation, amino acid transporter expression, and activity (P < 0.01) and increased placental protein expression of fatty acid transporting protein 4 (P < 0.05). Conclusions: Maternal DHA supplementation in pregnancy decreases placental inflammation and differentially modulates placental nutrient transport capacity and may mitigate adverse effects of maternal obesity on placental function.


Subject(s)
Dietary Supplements , Docosahexaenoic Acids/therapeutic use , Obesity/drug therapy , Placenta/drug effects , Adult , Blood Glucose/metabolism , Carrier Proteins/metabolism , Cytokines/blood , Docosahexaenoic Acids/metabolism , Fatty Acids/blood , Female , Fetal Development/drug effects , Hormones/blood , Humans , Infant, Newborn , Lipids/blood , Obesity/complications , Placenta/metabolism , Pregnancy , Pregnancy Complications , Young Adult
5.
Obstet Gynecol ; 129(6): 1040-1045, 2017 06.
Article in English | MEDLINE | ID: mdl-28486367

ABSTRACT

Intra-amniotic dye instillation is a useful tool for evaluation of equivocal cases of preterm prelabor rupture of membranes and for genetic amniocentesis in multifetal gestation. Indigo carmine, the most used and studied dye, is no longer available. We sought to provide a resource of potential dyes for clinical use that summarizes dosing along with maternal, fetal, and neonatal outcomes. We reviewed the literature evaluating the use of alternative agents. Sodium fluorescein has proven clinical usefulness but has side effects when used intravenously. Phenol-sulfonphthalein has reported clinical utility with no cases of maternal, fetal, or neonatal side effects; however, it is not currently available in the United States. Indocyanine green has been used in pregnancy for other indications. Oral phenazopyridine hydrochloride may lead to a false-positive diagnosis of preterm prelabor rupture of membranes. Evans blue and methylene blue have adverse fetal and neonatal effects. Of the dye options available, fluorescein is a readily available commercial option that has the best evidence supporting use and safety for these indications.


Subject(s)
Amniotic Fluid/chemistry , Coloring Agents/administration & dosage , Fetal Membranes, Premature Rupture/diagnosis , Prenatal Diagnosis/standards , Female , Fetal Membranes, Premature Rupture/diagnostic imaging , Humans , Injections , Pregnancy , Sensitivity and Specificity
6.
Gynecol Oncol Rep ; 17: 45-8, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27355001

ABSTRACT

•Management of cervical leiomyosarcoma in pregnancy requires a multidisciplinary approach.•Ovarian preservation is preferred in young patients with early stage cervical leiomyosarcoma.•Routine lymphadenectomy in patients with early stage cervical leiomyosarcoma is not useful.

7.
Am J Obstet Gynecol ; 212(2): 227.e1-7, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25132463

ABSTRACT

OBJECTIVE: Obese women are at increased risk to deliver a large infant, however, the underlying mechanisms are poorly understood. Fetal glucose availability is critically dependent on placental transfer and is linked to fetal growth by regulating the release of fetal growth hormones such as insulin. We hypothesized that (1) umbilical vein glucose and insulin levels and (2) placental glucose transporter (GLUT) expression and activity are positively correlated with early pregnancy maternal body mass index and infant birthweight. STUDY DESIGN: Subjects in this prospective observational cohort study were nondiabetic predominantly Hispanic women delivered at term. Fasting maternal and umbilical vein glucose and insulin concentrations were determined in 29 women with varying early pregnancy body mass index (range, 18.0-54.3) who delivered infants with birthweights ranging from 2800-4402 g. We isolated syncytiotrophoblast microvillous and basal plasma membranes from 33 placentas and determined the expression of GLUT-1 and -9 (Western blot) and glucose uptake (radiolabeled glucose). RESULTS: Birthweight was positively correlated with umbilical vein glucose and insulin and maternal body mass index. Umbilical vein glucose levels were positively correlated with placental weight and maternal body mass index, but not with maternal fasting glucose. Basal plasma membranes GLUT-1 expression was positively correlated with birthweight. In contrast, syncytiotrophoblast microvillous GLUT-1 and -9, basal plasma membranes GLUT-9 expression and syncytiotrophoblast microvillous and basal plasma membranes glucose transport activity were not correlated with birthweight. CONCLUSION: Because maternal fasting glucose levels and placental glucose transport capacity were not increased in obese women delivering larger infants, we speculate that increased placental size promotes glucose delivery to these fetuses.


Subject(s)
Birth Weight/physiology , Blood Glucose/metabolism , Glucose Transport Proteins, Facilitative/metabolism , Glucose Transporter Type 1/metabolism , Insulin/blood , Obesity/blood , Placenta/metabolism , Pregnancy Complications/blood , Adult , Body Mass Index , Case-Control Studies , Cohort Studies , Female , Fetal Macrosomia/blood , Fetal Macrosomia/metabolism , Humans , Infant, Newborn , Male , Maternal-Fetal Exchange/physiology , Obesity/metabolism , Organ Size , Placentation , Pregnancy , Pregnancy Complications/metabolism , Prospective Studies , Trophoblasts/metabolism , Umbilical Veins
SELECTION OF CITATIONS
SEARCH DETAIL
...